Enteric Disease Testing Market - Global Industry Analysis

Enteric Disease Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6502 Status : Upcoming

Description

Global Enteric Disease Testing Market: Overview

The enteric disease is an intestinal disorder caused due to the presence of foreign antigens like parasites, viral, or bacteria. The enteric disease is usually caused due to norovirus, rotavirus, salmonella, vibrio cholera, and others. Various symptoms of enteric disease include anorexia, nausea, vomiting, and abdominal cramps which may further lead to severe conditions like heavy removal of essential nutrients and fluids from the human body. However, the geriatric and pediatric age groups are comparatively more prone to such conditions due to their weak immune system. The enteric disease is surging as a major cause of morbidity all across the globe due to poor sanitation and drainage facilities.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Enteric Disease Testing Market: Growth Factors

The growing demand for the early diagnosis of enteric disease is the primary factor fuelling the growth of the global enteric disease testing market. The traditional diagnostic process of diagnosing and treating disease was the culture-based method that requires skilled staff along with long procedure periods. The introduction of molecular diagnostics will significantly revolutionize this disease testing market. The absence of proper hygiene due to the growing population in the urban as well as rural areas in developing economies is another important factor that is likely to significantly promulgate the growth of the global enteric disease testing market during the forecast period. However, the various other factors including poor sanitation, safe drinking water, and unhygienic conditions will further propel the prevalence of enteric diseases. The manufacturers are adopting several advanced strategies for the development of novel therapeutics for enteric disease. The growing support from governments along with the favorable reimbursement policies will encourage people to avail proper treatment for the enteric disease. Also, the growing initiatives by the government to improve the living standard especially among rural people is expected to positively shape the trajectory of the global enteric disease testing market during the forecast period. The emergence of advanced technologies like a polymerase chain reaction and enzyme-linked immunosorbent assay will help to overcome the underlying challenges in the field of enteric disease testing. However, the growing awareness among people regarding enteric disease and the benefits of early diagnosis & treatment will also influence the market positively.

Global Enteric Disease Testing Market: Segmentation

The global enteric disease testing market can be segmented into technology, therapeutics, and region.

By technology, the market can be segmented into gel microdroplets, diagnostic imaging, chromatography, flow cytometry, liposomes, artificial intelligence, information technology, differential light scattering, immunoassays, monoclonal antibodies, molecular diagnostics, and others. The molecular diagnostic segment accounts for the largest share in the global enteric disease testing market.

By therapeutics, the market can be segmented into shigellosis, salmonellosis, rotavirus, rhinovirus, enteroviruses, E. coli, cryptosporidium, campylobacter, and others. The E. coli segment holds hegemony over others due to its growing incidences among children.

Global Enteric Disease Testing Market: Regional analysis

Asia Pacific accounts for the largest share in the global enteric disease testing market due to the higher rate of migration of population from rural areas to urban areas. Also, the lack of proper sanitation and hygiene among people especially in countries like China and India is likely to propel the growth of the regional market in the forthcoming years. Moreover, the growing initiatives from the government to lower the rate of enteric disease in the region will also promulgate the growth.

North America is expected to witness a significant growth rate in the forthcoming years due to the ongoing technological advancements in the field of enteric disease testing. Moreover, the favorable reimbursement policies by the government in the region will also encourage people to undergo proper treatment, which in turn will escalate the growth of the regional market.

Global Enteric Disease Testing Market: Competitive Players

Some of the significant players in the global enteric disease testing market are Cepheid Inc., Becton Dickinson & Company, Biomerica, Inc., Pro-Lab Diagnostics, Inc., TECHLAB, Inc., Coris BoConcept, Quest Diagnostics, DiaSorin S.p.A., Trinity Biotech plc, bioMérieux SA, Alere, Inc., Bio-Rad Laboratories, Inc., and Meridian Bioscience, Inc.

Global Enteric Disease Testing Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

The growing demand for the early diagnosis of enteric disease is the primary factor fuelling the growth of the global enteric disease testing market. The traditional diagnostic process of diagnosing and treating disease was the culture-based method that requires skilled staff along with long procedure periods.

 

Some of the significant players in the global enteric disease testing market are Cepheid Inc., Becton Dickinson & Company, Biomerica, Inc., Pro-Lab Diagnostics, Inc., TECHLAB, Inc., Coris BoConcept, Quest Diagnostics, DiaSorin S.p.A., Trinity Biotech plc, bioMérieux SA, Alere, Inc., Bio-Rad Laboratories, Inc., and Meridian Bioscience, Inc.

Asia Pacific accounts for the largest share in the global enteric disease testing market due to the higher rate of migration of population from rural areas to urban areas. Also, the lack of proper sanitation and hygiene among people especially in countries like China and India is likely to propel the growth of the regional market in the forthcoming years.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social